ELOVL3 and hepatocellular carcinoma: Upregulated expression of ELOVL3 was identified in hepatocellular carcinoma and colorectal cancer, which was a risk factor for these cancer patients (Alnabulsi et al., 2019; Yuan et al., 2021).